Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03416621 · ClinicalTrials.gov registry record · Phase 3
Project Q Pilot: Smoking Cessation for Light Smokers
A Phase 3 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 3
- Development phase
- 31
- Enrollment target
NCT03416621: Completed Phase 3 study, sponsored by Duke University.
NCT03416621 is a Phase 3 study that has completed, run by Duke University. The registered enrollment target is 31 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03416621, a Phase 3 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate the feasibility, acceptability, and preliminary efficacy of an intervention to promote smoking cessation among light smokers.
Primary Outcome
Feasibility will be determined by number of participants that complete at least 2 study visits.
Interventions
- BEHAVIORAL Cognitive behavioral cessation counseling
- BEHAVIORAL Counseling and placebo drug intervention
- DRUG Counseling and active drug intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-05-17 |
| Est. Completion | 2020-02-29 |
| Phase | Phase 3 |
What the finished NCT03416621 record still lists
NCT03416621 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Cognitive behavioral cessation counseling is the first listed.
NCT03416621 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03416621 about?
NCT03416621 is a clinical study titled "Project Q Pilot: Smoking Cessation for Light Smokers". The purpose of this pilot study is to evaluate the feasibility, acceptability, and preliminary efficacy of an intervention to promote smoking cessation among light smokers.
What is the current status of trial NCT03416621?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 31 participants. The study started on 2018-05-17. Estimated completion is 2020-02-29.
What interventions are being tested in trial NCT03416621?
The interventions under investigation include: Cognitive behavioral cessation counseling (BEHAVIORAL), Counseling and placebo drug intervention (BEHAVIORAL), Counseling and active drug intervention (DRUG).
Who is sponsoring clinical trial NCT03416621?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03416621's enrollment target sits among peer trials
31 1914th of 2000 higher than 84 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI